HiMedia Laboratories Pvt. Ltd.’s Post

🚀 MITCON Biopharma Unveils Its High-Tech Multifunctioning Biotech Lab! 🔬🧬 We’re proud to introduce our state-of-the-art biotech lab, equipped with the latest high-tech instruments for advanced research in biochemistry, molecular biology, and clinical pathology. One such essential tool is the Digital Photo Colorimeter, used for precise absorbance (optical density) measurements at specific wavelengths. 🌡️✨ 🔎 Key Applications: ✅ Clinical & Medical Diagnostics – Blood analysis (hemoglobin estimation), urine & serum biochemical tests 🩸 ✅ Microbiology – Measuring bacterial growth, analyzing antibiotic effects 🦠 ✅ Molecular Biology – Quantifying DNA, RNA, proteins & biomolecule concentrations 🧪 With cutting-edge technology, MITCON Biopharma is redefining biotech research & diagnostics. Stay tuned for more innovations! 🚀 More more update visit: www.mitconbiopahrma.com #MITCONBiopharma #BiotechInnovation #ClinicalPathology #MolecularBiology #ResearchRevolution #Clinicalresearchjobs #pvjobs

🔬💡 Interested in trends and engineering challenges in Cell Culture Manufacturing? Check this white paper, the result of an insightful collaborative workshop with engineering and biotech stakeholders! https://lnkd.in/eDZdH_9u

𝗧𝗿𝗲𝗻𝗱𝘀 𝗮𝗻𝗱 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗶𝗻 𝗖𝗲𝗹𝗹 𝗖𝘂𝗹𝘁𝘂𝗿𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴. 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁.... ......the biotech market has seen incredible growth in recent decades, fueled by breakthroughs like single-use technologies, advanced cell lines, and cutting-edge bioreactors? With growing demands to reduce costs, improve efficiency, and scale production, innovation in bioprocessing has never been more crucial. To tackle these challenges, we brought together industry leaders and experts from High Tech NL Life Sciences, TU Delft, ReGEN Biomedical, Innovation Center for Advanced Therapies (ICAT), Scinus Cell Expansion B.V., and Sync Biosystems for an insightful workshop. The workshop’s objective was to establish a comprehensive understanding of the most critical technologies and competences required for cell culture manufacturing. Key focus areas included: - Manufacturing technologies for cell and gene therapy - Tissue engineering - Biopharmaceutical manufacturing Curious about the latest trends in cell culture manufacturing and the current and future technological challenges in the field? Download our white paper here 👉 https://lnkd.in/eT2N6C8S Or meet Mariette Geltink and Karel van Eijkeren next week at the SLAS (Society for Laboratory Automation and Screening) in San Diego, Booth #155! #cellculture #biotech #contractengineering #contractmanufacturing #iso13485

𝐍𝐆𝐒 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐫𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧: 𝐓𝐡𝐞 𝐁𝐚𝐜𝐤𝐛𝐨𝐧𝐞 𝐨𝐟 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 🔶 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dCvSuJSv 𝑻𝒉𝒆 𝒈𝒍𝒐𝒃𝒂𝒍 𝑵𝑮𝑺 𝒔𝒂𝒎𝒑𝒍𝒆 𝒑𝒓𝒆𝒑𝒂𝒓𝒂𝒕𝒊𝒐𝒏 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒏 𝒕𝒆𝒓𝒎𝒔 𝒐𝒇 𝒓𝒆𝒗𝒆𝒏𝒖𝒆 𝒘𝒂𝒔 𝒆𝒔𝒕𝒊𝒎𝒂𝒕𝒆𝒅 𝒕𝒐 𝒃𝒆 𝒘𝒐𝒓𝒕𝒉 $1.9 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2022 𝒂𝒏𝒅 𝒊𝒔 𝒑𝒐𝒊𝒔𝒆𝒅 𝒕𝒐 𝒓𝒆𝒂𝒄𝒉 $4.0 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2028, 𝒈𝒓𝒐𝒘𝒊𝒏𝒈 𝒂𝒕 𝒂 𝑪𝑨𝑮𝑹 𝒐𝒇 13.4%. Some of the prominent factors driving the growth of this market are advancements in NGS platforms, the declining cost of sequencing, the use of NGS as a substitute for PCR, as well as the increased efficiency of genotyping and preparation protocols for boosting the growth of the market. 🔶 𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜: 𝐓𝐡𝐞 𝐟𝐚𝐬𝐭𝐞𝐬𝐭-𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐫𝐞𝐠𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐍𝐆𝐒 𝐬𝐚𝐦𝐩𝐥𝐞 𝐩𝐫𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭. The #AsiaPacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to the rising focus on R&D activities, increasing adoption of #NGS for diagnostics, and technological development in NGS data analysis. 🌐 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Illumina Thermo Fisher Scientific PerkinElmer Pensionskasse der F. Hoffmann-La Roche AG Agilent Technologies Danaher Corporation Becton, Dickinson and Company Merck KGaA, Darmstadt, Germany QIAGEN Bio-Rad Laboratories Promega Corporation Eurofins Scientific Finland Oy BGI Genomics 10x Genomics Sysmex Corporation Psomagen Zymo Research Corp Takara Bio USA, Inc. Novogene. New England Biolabs Tecan Oxford Nanopore Technologies PacBio MEDGENOME Swift Biosciences

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐭𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 (𝐍𝐆𝐒) 𝐌𝐚𝐫𝐤𝐞𝐭! Download PDF Brochure: https://lnkd.in/dV2wiGwf The NGS landscape is experiencing remarkable growth, projected to double from $13B (2022) to $27B by 2027, with a robust 15.7% CAGR. Key Growth Drivers: - Breakthrough NGS technologies - Declining sequencing costs - Favorable regulatory environment The real game-changer? Sequencing services are emerging as the sweet spot, particularly: • Exome sequencing • RNA sequencing • De Novo sequencing • Custom & targeted solutions Leading innovators like CD Genomics and Eurofins Genomics are pioneering De Novo sequencing solutions, opening new frontiers in genomics research and precision medicine. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Illumina, Thermo Fisher Scientific, PerkinElmer, BGI Group, Agilent Technologies, Eurofins Scientific Finland Oy, Pacific Bio, Oxford Nanopore Technologies, QIAGEN, F. Hoffmann-La Roche AG (Switzerland), Brooks Automation, Psomagen, 10x Genomics, TECAN GROUP, Zymo Research Corp, Takara Bio Inc., Promega Corporation , CD Genomics, New England Biolabs, and Novogene Other Companies that are Operating in this Market Globally: hylabs (Hy Laboratories Ltd)    Unilabs - Serving Pharma Norgen Biotek AID Genomics Institute of Bioinformatics (IOB) CJ Bioscience POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company   Agendia Roche NimbleGen Inc. Jnana Therapeutics LifeMine Therapeutics MaxCyte, Inc. Locus Biosciences, Inc. Life Edit Therapeutics Clear Labs xilis Kelonia Therapeutics  Autolus Therapeutics Tyra Biosciences Eurofins Genomics India Pvt Ltd. Xcelris Labs Ltd. #Genomics #Biotechnology #Healthcare #Innovation #FutureOfMedicine #HealthTech

Genomics Market worth $83.1 billion by 2028 Download PDF Brochure:-https://lnkd.in/dsnBN37H The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche, Ltd. (Switzerland), 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Oxford Nanopore Technologies 23andMe PacBio Genentech Twist Bioscience Natera SomaLogic Veracyte, Inc. Personalis, Inc. Guardant Health GRAIL Helix Adaptive Biotechnologies Corp. 10x Genomics Invitae Myriad Genetics CRISPR Therapeutics Editas Medicine Beam Therapeutics bluebird bio Regeneron Pharmaceuticals, Inc. Arbor Biotechnologies Ginkgo Bioworks, Inc. Synthego Corporation Human Longevity, Inc. GENOOX Nebula Genomics BIONANO GENOMICS UK LIMITED Alnylam Pharmaceuticals Sema4 Revvity Tempus AI X-Chem, Inc. AstraZeneca Bio-Rad Laboratories WuXi NextCODE Genomics Novogene BGI Genomics #genomics #precisionmedicine #crispr #personalizedmedicine #dnasequencing

🚀 Exciting News from OMAPiX! 🚀 As a premier CRO located in Frederick, Maryland, USA, OMAPiX has expanded multiomics capabilities to now include:  10x Genomics Visium HD: Enabling spatial, whole transcriptome analysis with 2um resolution and  Xenium: A high-complexity in situ sequencing platform that can characterize up to 5,000 genes with ultra-precise subcellular spatial imaging. OMAPiX supports pharma, biotech, and academia, empowering scientists to transform their research & development, gain unprecedented insights into tissue samples, and support drug development, testing and clinical trials. Reach out to learn how OMAPiX’s advanced solutions can help transform and accelerate your scientific breakthroughs! #SpatialTranscriptomics #Discovery #DrugDevelopment #ResearchInnovation #OMAPiX #Biotech #Pharma #AcademicResearch

Pyrosequencing Market Latest Report 2024-2030 For Additional Information, Get a Sample Copy>>> https://lnkd.in/d95-AjfV The Pyrosequencing Market refers to the industry centered around the development, production, and commercialization of pyrosequencing technology, a DNA sequencing method based on detecting pyrophosphate release during nucleotide incorporation. This market includes instruments, reagents, and software used in genetic analysis, research, diagnostics, and personalized medicine. Pyrosequencing is widely used in applications such as SNP (single nucleotide polymorphism) detection, DNA methylation analysis, and microbial identification. The market is driven by advancements in genomics, the growing demand for precision medicine, and the need for rapid, accurate DNA sequencing technologies. #KeyPlayers::: QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (United States), Illumina (United States), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (United States), GE HealthCare (United States), Agilent Technologies (United States), PerkinElmer (United States), Sartorius AG (Germany), Promega Corporation (United States), Oxford Nanopore Technologies Ltd. (United Kingdom), Dantec Dynamics A/S (Denmark), NimbleGen Systems GmbH (United States), Pacific Biosciences of California, Inc. (United States), MacroGenics, Inc.. (South Korea) #PyrosequencingMarket #Pyrosequencing #sequencing #htfmi #htf HTF Market Intelligence Consulting Pvt Ltd

🧬 The Next-Generation Sequencing (NGS) Market Set for Explosive Growth! 📈 📥 Download Complete PDF: https://lnkd.in/dV2wiGwf Exciting market insights reveal that the NGS sector is poised to more than double, reaching USD 27.0 billion by 2027 from USD 13.0 billion in 2022 (CAGR: 15.7%)! Key Growth Drivers: • Surging demand for precision medicine • Rising applications in drug discovery • Expanding use in agricultural genomics • Growing adoption in clinical diagnostics Market Segments Making Waves: 🧪 Products & Services - Consumables - Cutting-edge platforms - Specialized services 🔬 Technologies - Sequencing by Synthesis (SBS) - Revolutionary Nanopore tech 🏢 Key Players - Pharmaceutical companies - Biotech firms - Academic institutions 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China) Other Companies that are Operating in this Market Globally: Roche Sequencing USA GRAIL MEDGENOME Singular Genomics New England Biolabs CareDx, Inc. Ultima Genomics siParadigm Diagnostic Informatics Watchmaker Genomics Roche NimbleGen Inc. Clear Labs Molecular Testing Labs Progenesis Psomagen Hematogenix GENEWIZ from Azenta Life Sciences   Genotypic Technology Igentify National Institute for Communicable Diseases (NICD) Eurofins Genomics Gubra Hoora Pharma (Pvt.) Ltd. Macrogen Europe Nucleome Informatics Pvt Ltd #Biotechnology #Genomics #Healthcare #MarketGrowth #Innovation #LifeSciences #PrecisionMedicine #NGS #BioinformaticsRevolution